CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 39 filers reported holding CTI BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,954,268 | +18.8% | 465,302 | +70.0% | 0.00% | 0.0% |
| Q4 2022 | $1,645,316 | -99.9% | 273,763 | -17.0% | 0.00% | 0.0% |
| Q3 2022 | $1,919,471,000 | +1494.4% | 329,806 | +1535.5% | 0.00% | – |
| Q2 2022 | $120,391,000 | +48056.4% | 20,166 | +7314.0% | 0.00% | – |
| Q1 2020 | $250,000 | -41.9% | 272 | 0.0% | 0.00% | – |
| Q4 2019 | $430,000 | -91.6% | 272 | -95.5% | 0.00% | – |
| Q3 2019 | $5,105,000 | -2.6% | 6,099 | 0.0% | 0.00% | – |
| Q2 2019 | $5,241,000 | -61.0% | 6,099 | -56.0% | 0.00% | – |
| Q1 2019 | $13,443,000 | +1930.7% | 13,856 | +1436.1% | 0.00% | – |
| Q4 2018 | $662,000 | -81.6% | 902 | -46.0% | 0.00% | – |
| Q3 2018 | $3,607,000 | -56.6% | 1,670 | 0.0% | 0.00% | – |
| Q2 2018 | $8,317,000 | – | 1,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |